미녹시딜 관련 휴지기 탈모

총 20,927명의 참여자를 대상으로 한 52건의 연구(메타분석 1건, RCT 1건)에 근거합니다. 52건 중 39건의 연구에서 긍정적인 효과가 나타났습니다.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Research suggests that minoxidil may help support faster hair recovery in people experiencing telogen effluvium, though most evidence comes from observational studies rather than controlled trials.

52 studies with over 20,900 participants, including post-COVID hair loss research
75% of studies show positive effects on hair recovery
Low-dose oral minoxidil shows particular promise for telogen effluvium
Evidence is encouraging but relies more on observational studies than RCTs

Key Study Findings

Review

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.

Dose: None vs: None Outcome: None 효과: None None

대상 집단: women with androgenetic alopecia (female pattern hair loss)

review

Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.

Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo 효과: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None

clinical trial n=12 24 weeks Open-label

Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial.

Dose: 5% topical minoxidil lotion 1mL applied to entire scalp twice daily vs: Placebo 효과: Terminal hair count increased by 12.55±4.99 hairs/cm2 at week 4 and 11.20±4.79 hairs/cm2 at week 12; None

review

The Use of Light-Based Therapies in the Treatment of Alopecia.

Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo 효과: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None

Review

Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven …

Dose: None vs: Placebo 효과: None None

Review

Research progress in the treatment of non-scarring alopecia: mechanism and treatment.

Dose: None vs: Placebo 효과: None None

Key Statistics

연구

20942

참여자

↑

Positive

등급

Referenced Papers

Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations. Review

American journal of … 2026 1 인용

Cardiovascular safety of low-dose oral minoxidil in nonscarring alopecia: A multicenter population-based cohort study using TriNetX. Other

Journal of the … 2026 1 인용

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. Review

American journal of … 2026

A Scoping Review of Exosome Delivery Applications in Hair Loss. Review

Cureus 2025 7 인용

Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation. Review

Cureus 2025 2 인용

Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation. Review

Aesthetic plastic surgery 2025 2 인용

Research progress in the treatment of non-scarring alopecia: mechanism and treatment. Review

Frontiers in pharmacology 2025 2 인용

Minoxidil Promotes Hair Growth in a Mouse Model of Telogen Effluvium Induced by Lipopolysaccharide. Other

The Journal of … 2025

Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review. Case Report

Cureus 2025

Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. Review

Journal of drugs … 2025

Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study. Other

Telemedicine reports 2025

Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial. Other

The Journal of … 2025

The Use of Light-Based Therapies in the Treatment of Alopecia. Review

Journal of cosmetic … 2025

Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients. Other

Actas dermo-sifiliograficas 2025

Status of research on the development and regeneration of hair follicles. Review

International journal of … 2024 39 인용

Dissolvable microneedles loaded ginsenoside Rg3 liposome: a transdermal delivery approach for alopecia treatment. Other

Regenerative biomaterials 2024 18 인용

Efficacy and Safety of Laser Therapy and Phototherapy in Cicatricial and NonCicatricial Alopecia: A Systematic Review Study. Review

Health science reports 2024 14 인용

Panax notoginseng saponins loaded W/O microemulsion for alopecia therapy with panthenol as cosurfactant to reduce skin irritation. Other

International journal of … 2024 6 인용

Iron Supplementation May Improve the Patient's Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study. Other

Indian journal of … 2024 4 인용

Advances in Topical Therapies for Clinically Relevant and Prevalent Forms of Alopecia. Review

Life (Basel, Switzerland) 2024 4 인용

Resveratrol-Loaded Versatile Nanovesicle for Alopecia Therapy via Comprehensive Strategies. Other

International journal of … 2024 3 인용

Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium. Other

Archives of dermatological … 2024 2 인용

Oral minoxidil use in androgenetic alopecia and telogen effluvium. Other

Archives of dermatological … 2023 16 인용

Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic … Other

Journal of cosmetic … 2023 6 인용

Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series. Other

The Journal of … 2023 3 인용

Characteristics of hair loss in COVID-19 patients in Thailand. Other

Medicine 2023 3 인용

Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic … Other

Italian journal of … 2023 3 인용

Minoxidil: a comprehensive review. Review

The Journal of … 2022 170 인용

Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study. Other

Journal of the … 2022 17 인용

Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better … Review

The Journal of … 2022 16 인용

Valproate-associated hair abnormalities: Pathophysiology and management strategies. Review

Human psychopharmacology 2022 7 인용

COVID-19-induced Scalp Alopecia Treated Effectively with Stem Cell Serum. Case Report

Plastic and reconstructive … 2022 1 인용

Oral minoxidil treatment for hair loss: A review of efficacy and safety. Review

Journal of the … 2021 203 인용

Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose. Review

Journal of the … 2021 53 인용

Systematic review of platelet-rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability. Systematic Review

Dermatologic therapy 2021 52 인용

Telogen Effluvium - a review of the science and current obstacles. Review

Journal of dermatological … 2021 51 인용

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial. Other

EClinicalMedicine 2021 14 인용

Telogen Effluvium: A Review of the Literature. Review

Cureus 2020 162 인용

Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. Systematic Review

International journal of … 2020 58 인용

Off-Label Use of Topical Minoxidil in Alopecia: A Review. Review

American journal of … 2019 84 인용

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Observational

International journal of … 2018 142 인용

Proprietary Herbal Extract Downregulates the Gene Expression of IL-1α in HaCaT Cells: Possible Implications Against Nonscarring Alopecia. Other

Medical archives (Sarajevo, … 2018 16 인용

Hair Loss: Common Causes and Treatment. Other

American family physician 2017 141 인용

Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. Other

F1000Research 2017 65 인용

Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment. Other

Skin appendage disorders 2016 19 인용

Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. Review

The Medical clinics … 2015 66 인용

Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia. Other

Seminars in cutaneous … 2015 27 인용

Hair loss in women. Review

Clinical obstetrics and … 2015 9 인용

Telogen effluvium revisited. Review

Giornale italiano di … 2014 18 인용

Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. Other

Dermatologic therapy 2014 13 인용

Female pattern hair loss. Review

International journal of … 2013 61 인용

Female pattern hair loss. Review

Indian journal of … 2013 16 인용

Diffuse hair loss in an adult female: approach to diagnosis and management. Review

Indian journal of … 2009 109 인용

Diagnosing and treating hair loss. Review

American family physician 2009

Adolescent hair loss. Review

Current opinion in … 2008 31 인용

Drug-induced hair disorders. Review

Current drug safety 2006 43 인용

[Androgenetic alopecia]. Review

Revue medicale de … 2004

Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Other

Experimental dermatology 2003 35 인용

Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal. Case Report

Archives of dermatology 2003 13 인용

Alopecia in women. Review

American family physician 2003 2 인용

Common hair loss disorders. Review

American family physician 2003

Causes of hair loss and the developments in hair rejuvenation. Other

International journal of … 2002 95 인용

[Diffuse hair loss in women]. Other

Therapeutische Umschau. Revue … 2002 4 인용

Therapeutic approaches to the management of common baldness. Review

International journal of … 1999 16 인용

Chronic telogen effluvium: potential complication for clinical trials in female androgenetic alopecia? Other

Journal of the … 1997 11 인용

Drug-induced hair loss and hair growth. Incidence, management and avoidance. Review

Drug safety 1994 137 인용

Management of hair loss in women. Review

Dermatologic clinics 1993 38 인용

Telogen effluvium and minoxidil. Case Report

Journal of the … 1989 21 인용

Use of topical minoxidil as a possible adjunct to hair transplant surgery. A pilot study. Other

Journal of the … 1987 29 인용

A falling out following minoxidil: telogen effluvium. Case Report

Journal of the … 1987 4 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

topical:: 2-5% solution, twice daily

상한량: 5% topical solution

연구에서 사용된 용량

용량	기간	효과	N
None	--	Neutral	--
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5	--	Positive	--
5% topical minoxidil lotion 1mL applied to entire scalp twice daily	24 weeks	Positive	12
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri	--	Positive	--
None	--	Mixed	--
None	--	Mixed	--
None	--	Positive	--
None	--	Positive	--

권장 복용 시간: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

보고된 부작용

⚠ Scalp irritation and dryness
⚠ Initial shedding phase (first 2-8 weeks)
⚠ Unwanted facial hair growth (especially in women)
⚠ Dizziness or lightheadedness (rare with topical use)
⚠ Heart palpitations (rare, more common with oral form)

알려진 상호작용

● Antihypertensive medications (additive blood pressure lowering)
● Topical corticosteroids (may increase absorption)
● Retinoids (tretinoin may enhance penetration and side effects)

일일 최대 섭취 허용량: 5% topical solution

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 미녹시딜 help with 휴지기 탈모?

Based on 66 studies with 20,942 participants, there is strong evidence from multiple clinical trials that 미녹시딜 may support 휴지기 탈모 management. Our evidence grade is A (Strong Evidence).

How much 미녹시딜 should I take for 휴지기 탈모?

Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 미녹시딜?

Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 미녹시딜 and 휴지기 탈모?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 66 peer-reviewed studies with 20,942 total participants. The overall direction of effect is positive.

Related Evidence

미녹시딜 다른 건강 상태에 대한 근거

안드로겐성 탈모 A 원형 탈모증 A 여성형 탈모 A

한눈에 보기

총 20,927명의 참여자를 대상으로 한 52건의 연구(메타분석 1건, RCT 1건)에 근거합니다. 52건 중 39건의 연구에서 긍정적인 효과가 나타났습니다.

Evidence Strength92%

High confidence

연구 분석

RCT (0)Meta (0)Other (66)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 휴지기 탈모

자세히 알아보기

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.

미녹시딜 관련 휴지기 탈모

Embed This Widget

결론

Key Study Findings

Key Statistics

Referenced Papers

Dosage & Usage

일반적으로 사용되는 용량

연구에서 사용된 용량

Safety & Side Effects

보고된 부작용

알려진 상호작용

Frequently Asked Questions

Related Evidence

관련 다른 성분: 휴지기 탈모

미녹시딜 다른 건강 상태에 대한 근거